Registered number: 06322035
For the year ended 31 July 2025
Lydian Care Ltd
Company Information
Lydian Care Ltd
Contents
Lydian Care Ltd
Strategic report
For the year ended 31 July 2025
The director presents his Strategic report on Lydian Care Ltd ("the Company") for the year ended 31 July 2025.
The principal activity of the Company during the year was the provision of care services.
The profit and loss account shows turnover of £13,668,430 (2024 (restated): £12,899,728) and profit before tax of £1,464,012 (2024 (restated): £1,881,878). Net assets at 31 July 2025 were £2,434,427 (2024 (restated): £1,500,051).
The director considers the results for the year and the financial position of the Company at the year end to be satisfactory and expects the Company to maintain its present level of activity in the foreseeable future.
The profit and loss account shows turnover of £13,668,430 (2024 (restated): £12,899,728) and profit before tax of £1,464,012 (2024 (restated): £1,881,878). Net assets at 31 July 2025 were £2,434,427 (2024 (restated): £1,500,051).
The director considers the results for the year and the financial position of the Company at the year end to be satisfactory and expects the Company to maintain its present level of activity in the foreseeable future.
The Company's operations expose it to a variety of financial risks that include the effects of credit risk and liquidity risk. The Company has in place a risk management programme that seeks to limit the adverse effects on the financial performance of the Company.
Financial risk management
Given the size of the Company, the directors have not delegated the responsibility of monitoring financial risk management to a sub committee of the board. The policies set by the board of directors are implemented by the Company's finance department.
Price risk
The Company is exposed to price risk as a result of its operations in relation to contracts with customers, which can affect its financial performance. The Company’s policy is to draw on its extensive market knowledge and customer relationships to mitigate the impact of price changes wherever possible, and the director will revisit the appropriateness of this policy should the Company's operation change in size or nature.
Credit risk
Credit risk arises from cash and cash equivalents with banks and financial institutions, as well as credit exposure to customers. The Company has implemented policies that require appropriate credit checks on potential customers before sales are made. The amount of exposure to individual customers is subject to a limit, which is reassessed regularly by the board. The financial position of banks and financial institutions utilised is regularly assessed by the director.
Liquidity risk
The Company mitigates liquidity risk by managing cash generated by its operations to ensure the Company has sufficient available funds for operations and planned expansions.
Cashflow risk
The Company has no borrowings or financial instruments that give rise to material exposures. Accordingly the director considers that there is no material exposure to cashflow risk.
Financial risk management
Given the size of the Company, the directors have not delegated the responsibility of monitoring financial risk management to a sub committee of the board. The policies set by the board of directors are implemented by the Company's finance department.
Price risk
The Company is exposed to price risk as a result of its operations in relation to contracts with customers, which can affect its financial performance. The Company’s policy is to draw on its extensive market knowledge and customer relationships to mitigate the impact of price changes wherever possible, and the director will revisit the appropriateness of this policy should the Company's operation change in size or nature.
Credit risk
Credit risk arises from cash and cash equivalents with banks and financial institutions, as well as credit exposure to customers. The Company has implemented policies that require appropriate credit checks on potential customers before sales are made. The amount of exposure to individual customers is subject to a limit, which is reassessed regularly by the board. The financial position of banks and financial institutions utilised is regularly assessed by the director.
Liquidity risk
The Company mitigates liquidity risk by managing cash generated by its operations to ensure the Company has sufficient available funds for operations and planned expansions.
Cashflow risk
The Company has no borrowings or financial instruments that give rise to material exposures. Accordingly the director considers that there is no material exposure to cashflow risk.
Page 1
Lydian Care Ltd
Strategic report (continued)
For the year ended 31 July 2025
The director considers the key performance indicators to be turnover and operating profit. Turnover for the year was £13,668,430 (2024 (restated): £12,899,728) and operating profit was £1,463,889 (2024 (restated): £1,881,085). The director is pleased with the improvement in the Company's key performance indicators for the year despite cost increases that have impacted the business.
This report was approved by the board on 29 April 2026 and signed on its behalf.
Page 2
Lydian Care Ltd
Director's report
For the year ended 31 July 2025
The director presents his report and the audited financial statements for the year ended 31 July 2025.
The director is responsible for preparing the Strategic report, the Director's report and the financial statements in accordance with applicable law and regulations.
In preparing these financial statements, the director is required to:
∙select suitable accounting policies for the Company's financial statements and then apply them consistently;
∙make judgements and accounting estimates that are reasonable and prudent;
∙prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Company will continue in business.
The director is responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and to enable him to ensure that the financial statements comply with the Companies Act 2006. He is also responsible for safeguarding the assets of the Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
The profit for the year, after taxation, amounted to £1,108,841 (2024 (restated) - £1,398,336).
A dividend of £174,465 (2024: £788,797) was paid during the financial year. The directors do not recommend the payment of a final dividend.
The prior year comparatives have been restated to correct the revenue recognition of a receipt received in the 2025 financial year, as explained in note 17 to the financial statements.
The prior year comparatives have been restated to correct the revenue recognition of a receipt received in the 2025 financial year, as explained in note 17 to the financial statements.
The director who served during the year and up to the date of signing these financial statements was:
The directors consider the results for the year and the position of the company at the year end to be satisfactory and expect the company to maintain its present level of activity in the foreseeable future.
The Company incurred no research and development costs in the current year.
Page 3
Lydian Care Ltd
Director's report (continued)
For the year ended 31 July 2025
During the year, the policy of providing employees with information about the Company has continued through internal media methods in which employees have also been encouraged to present their suggestions and views on the Company's performance. Regular meetings are held between local management and employees to allow a free flow of information and ideas.
Details of financial risk management is provided in the Strategic report in accordance with Section 414C(11) of the Companies Act 2006.
There have been no significant events affecting the Company since the year end.
The auditor, Sumer Auditco NI Limited, will be proposed for reappointment in accordance with section 485 of the Companies Act 2006.
This report was approved by the board on 29 April 2026 and signed on its behalf.
Page 4
Lydian Care Ltd
Independent auditor's report to the members of Lydian Care Ltd
We have audited the financial statements of Lydian Care Ltd (the 'Company') for the year ended 31 July 2025, which comprise the Statement of comprehensive income, the Balance sheet, the Statement of changes in equity and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).
In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.
Page 5
Lydian Care Ltd
Independent auditor's report to the members of Lydian Care Ltd (continued)
The other information comprises the information included in the Annual Report other than the financial statements and our Auditor's report thereon. The director is responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
In our opinion, based on the work undertaken in the course of the audit:
∙the information given in the Strategic report and the Director's report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
∙the Strategic report and the Director's report have been prepared in accordance with applicable legal requirements.
In the light of the knowledge and understanding of the Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic report or the Director's report.
Page 6
Lydian Care Ltd
Independent auditor's report to the members of Lydian Care Ltd (continued)
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
We gained an understanding of the legal and regulatory framework applicable to the Company and the industry in which they operate, and considered the risk of acts by the Company that were contrary to applicable laws and regulations, including fraud. We considered the opportunities and incentives that may exist within the Company for fraud and identified the greatest potential for fraud is in relation to management override of controls and the recognition of revenue.
We designed audit procedures to respond to these risks, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion. Our audit procedures included: enquiries of management about their own identification and assessment of risks of irregularities, testing the design and implementation of controls relating to the risks, sample testing of journals posted during the year, ensuring that the accounting policies have been complied with and a review of areas of judgement for indicators of management bias to address the risks.
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditor's report.
Page 7
Lydian Care Ltd
Independent auditor's report to the members of Lydian Care Ltd (continued)
This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.
for and on behalf of
Statutory Auditors
Page 8
Lydian Care Ltd
Statement of comprehensive income
For the year ended 31 July 2025
Page 9
Lydian Care Ltd
Registered number: 06322035
Balance sheet
As at 31 July 2025
The financial statements were approved and authorised for issue by the board and were signed on its behalf on 29 April 2026 .
The notes on pages 12 to 24 form part of these financial statements.
Page 10
Lydian Care Ltd
Statement of changes in equity
For the year ended 31 July 2025
Page 11
Lydian Care Ltd
Notes to the financial statements
For the year ended 31 July 2025
Lydian Care Ltd (the Company) is a private company limited by shares and incorporated in England and Wales. The registered office is Unit 16, The Mead Business Centre, Mead Lane, Hertford, Herts, SG13 7BJ. The address of the principal place of business is 33 Main Street, Newcastle, Northern Ireland, BT33 0AD.
2.Accounting policies
The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland (FRS 102) and the Companies Act 2006.
The presentational and functional currency is GBP. The financial statements have been rounded to the nearest £.
The following principal accounting policies applied are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
The Company has taken advantage of the following disclosure exemptions in preparing these financial statements, as permitted by the FRS 102:
∙the requirements of Section 7 Statement of Cash Flows;
∙the requirements of Section 3 Financial Statement Presentation paragraph 3.17(d);
∙the requirements of Section 11 Financial Instruments paragraphs 11.42, 11.44 to 11.45, 11.47, 11.48(a)(iii), 11.48(a)(iv), 11.48(b) and 11.48(c);
∙the requirements of Section 12 Other Financial Instruments paragraphs 12.26 to 12.27, 12.29(a), 12.29(b) and 12.29A;
∙the requirements of Section 33 Related Party Disclosures paragraph 33.7.
This information is included in the consolidated financial statements of Lydian Holdings Ltd as at 31 July 2025 and these financial statements may be obtained from Companies House.
The financial statements have been prepared on a going concern basis. The director has considered all available information which is at least 12 months from the date when the financial statements are authorised for issue.
Page 12
Lydian Care Ltd
Notes to the financial statements
For the year ended 31 July 2025
2.Accounting policies (continued)
Page 13
Lydian Care Ltd
Notes to the financial statements
For the year ended 31 July 2025
2.Accounting policies (continued)
Current or deferred taxation assets and liabilities are not discounted.
At each reporting date the Company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.
Page 14
Lydian Care Ltd
Notes to the financial statements
For the year ended 31 July 2025
2.Accounting policies (continued)
Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.
Depreciation is provided on the following basis:
The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.
Provisions are measured as the best estimate of the amount required to settle the obligation, taking into account the related risks and uncertainties.
Page 15
Lydian Care Ltd
Notes to the financial statements
For the year ended 31 July 2025
2.Accounting policies (continued)
Basic financial assets
Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.
Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.
Other financial assets
Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.
Impairment of financial assets
At the end of each reporting period financial assets measured at amortised cost are assessed for objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.
If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.
Basic financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.
Basic financial liabilities, which include trade and other creditors, bank loans and other loans are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.
Page 16
Lydian Care Ltd
Notes to the financial statements
For the year ended 31 July 2025
2.Accounting policies (continued)
Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.
Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.
Ordinary shares are classified as equity. Share capital represents the nominal value of shares that have been issued and fully paid. Proceeds received in excess of the nominal value of shares issued are recorded within the share premium account.
The whole of the turnover is attributable to the principal activity of the Company.
Page 17
Lydian Care Ltd
Notes to the financial statements
For the year ended 31 July 2025
Page 18
Lydian Care Ltd
Notes to the financial statements
For the year ended 31 July 2025
There were no factors that may affect future tax charges.
Page 19
Lydian Care Ltd
Notes to the financial statements
For the year ended 31 July 2025
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
||||
|
|
Page 20
Lydian Care Ltd
Notes to the financial statements
For the year ended 31 July 2025
Page 21
Lydian Care Ltd
Notes to the financial statements
For the year ended 31 July 2025
|
|
||
|
|
||
|
|
||
|
|
||
|
|
Profit and loss account
Page 22
Lydian Care Ltd
Notes to the financial statements
For the year ended 31 July 2025
During the year, the Company identified that a material trade debtor, totalling £1,038,268, relating to the previous financial year had not been recognised in the prior year financial statements. The omission arose due to an administrative oversight in the year end turnover and receivables reconciliation process.
In accordance with FRS 102 Section 10 – Accounting Policies, Estimates and Errors, the Company has corrected this error retrospectively. The comparative figures for the prior year have been restated to reflect the recognition of the debtor and the associated turnover.
The correction has resulted in an increase in trade debtors, turnover and retained earnings in the prior year. The adjustment has no impact on the current year profit or cash flows.
There has been a decrease to the Corporation tax payable balance of £257,567.
In accordance with FRS 102 Section 10 – Accounting Policies, Estimates and Errors, the Company has corrected this error retrospectively. The comparative figures for the prior year have been restated to reflect the recognition of the debtor and the associated turnover.
The correction has resulted in an increase in trade debtors, turnover and retained earnings in the prior year. The adjustment has no impact on the current year profit or cash flows.
There has been a decrease to the Corporation tax payable balance of £257,567.
The Company operates a defined contributions pension scheme. The assets of the scheme are held separately from those of the Company in an independently administered fund. The pension cost charge represents contributions payable by the Company to the fund and amounted to £304,054 (2024: £284,056). Contributions totaling £34,534 (2024: £123,830) were payable to the fund at the balance sheet date and are included in creditors.
Page 23
Lydian Care Ltd
Notes to the financial statements
For the year ended 31 July 2025
The Company's immediate and ultimate parent undertaking is Lydian Holdings Ltd, a company incorporated in Northern Ireland.
The largest and smallest group in which the results of Lydian Care Ltd are consolidated is that headed by Lydian Holdings Ltd. Copies of these financial statements can be obtained from Companies House.
The ultimate controlling parties are Pierre and Claire Burns.
The largest and smallest group in which the results of Lydian Care Ltd are consolidated is that headed by Lydian Holdings Ltd. Copies of these financial statements can be obtained from Companies House.
The ultimate controlling parties are Pierre and Claire Burns.
Page 24